118 related articles for article (PubMed ID: 36161287)
21. Contemporary surgical treatment of advanced-stage melanoma.
Essner R; Lee JH; Wanek LA; Itakura H; Morton DL
Arch Surg; 2004 Sep; 139(9):961-6; discussion 966-7. PubMed ID: 15381613
[TBL] [Abstract][Full Text] [Related]
22. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F; Zhong Q; Huang Z; Lian M; Fang J
Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
[No Abstract] [Full Text] [Related]
23. Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study.
Verver D; Louwman WJ; Koljenović S; Verhoef C; Grünhagen DJ; van Akkooi ACJ
Eur J Cancer; 2018 Mar; 92():100-107. PubMed ID: 29217356
[TBL] [Abstract][Full Text] [Related]
24. Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib.
Saiag P; Robert C; Grob JJ; Mortier L; Dereure O; Lebbe C; Mansard S; Grange F; Neidhardt EM; Lesimple T; Machet L; Bedane C; Maillard H; Dalac-Rat S; Nardin C; Szenik A; Denden A; Dutriaux C
Eur J Cancer; 2021 Sep; 154():57-65. PubMed ID: 34243078
[TBL] [Abstract][Full Text] [Related]
25. Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial).
Googe PB; Theocharis S; Pergaris A; Li H; Yan Y; McKenna EF; Moschos SJ
Curr Probl Cancer; 2022 Jun; 46(3):100862. PubMed ID: 35398635
[TBL] [Abstract][Full Text] [Related]
26. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
[TBL] [Abstract][Full Text] [Related]
27. High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors.
Teterycz P; Jagodzińska-Mucha P; Cybulska-Stopa B; Mariuk-Jarema A; Kozak K; Koseła-Paterczyk H; Czarnecka AM; Rajczykowski M; Dziura R; Galus Ł; Mackiewicz J; Świtaj T; Klimczak A; Falkowski S; Suwiński R; Ziobro M; Ługowska I; Rutkowski P
Melanoma Res; 2018 Oct; 28(5):435-441. PubMed ID: 29782381
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
29. A review of the AJCC melanoma staging system in the TNM classification (eighth edition).
Ogata D; Namikawa K; Takahashi A; Yamazaki N
Jpn J Clin Oncol; 2021 Apr; 51(5):671-674. PubMed ID: 33709104
[TBL] [Abstract][Full Text] [Related]
30. Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.
Hieken TJ; Glasgow AE; Enninga EAL; Kottschade LA; Dronca RS; Markovic SN; Block MS; Habermann EB
J Womens Health (Larchmt); 2020 Sep; 29(9):1160-1167. PubMed ID: 32105561
[No Abstract] [Full Text] [Related]
31. High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy.
Bartlett EK; Flynn JR; Panageas KS; Ferraro RA; Sta Cruz JM; Postow MA; Coit DG; Ariyan CE
Cancer; 2020 Jan; 126(1):76-85. PubMed ID: 31584709
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
Abdel-Rahman O
PLoS One; 2017; 12(11):e0188450. PubMed ID: 29182656
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of two tumour staging classifications in patients with sinonasal mucosal melanoma.
Houette A; Gilain L; Mulliez A; Mom T; Saroul N
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Nov; 133(5):313-317. PubMed ID: 27291483
[TBL] [Abstract][Full Text] [Related]
34. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for survival of patients treated systemically for disseminated melanoma.
Eton O; Legha SS; Moon TE; Buzaid AC; Papadopoulos NE; Plager C; Burgess AM; Bedikian AY; Ring S; Dong Q; Glassman AB; Balch CM; Benjamin RS
J Clin Oncol; 1998 Mar; 16(3):1103-11. PubMed ID: 9508197
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
[TBL] [Abstract][Full Text] [Related]
37. [The 8th edition of the American Joint Committee on Cancer staging system provide improved prognostic accuracy in T1-2N1M0 postmastectomy breast cancer patients].
Sun GY; Wang SL; Tang Y; Yang Y; Fang H; Wang JY; Jing H; Zhang JH; Jin J; Song YW; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Wang WH; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):615-623. PubMed ID: 31434454
[No Abstract] [Full Text] [Related]
38. Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.
Hauschild A; Larkin J; Ribas A; Dréno B; Flaherty KT; Ascierto PA; Lewis KD; McKenna E; Zhu Q; Mun Y; McArthur GA
JAMA Oncol; 2018 Oct; 4(10):1382-1388. PubMed ID: 30073321
[TBL] [Abstract][Full Text] [Related]
39. The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status.
Dogrusöz M; Bagger M; van Duinen SG; Kroes WG; Ruivenkamp CA; Böhringer S; Andersen KK; Luyten GP; Kiilgaard JF; Jager MJ
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):833-842. PubMed ID: 28159971
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]